Acadia Pharmaceuticals (ACAD) EPS (2010 - 2026)
Acadia Pharmaceuticals (ACAD) EPS from Jun 30, 2010 to Mar 31, 2026. The TTM Acadia Pharmaceuticals (ACAD) EPS is $2.21. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Acadia Pharmaceuticals (ACAD) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +60.83% |
| 3 Years TTM | +132.98% |
Annual EPS change of Acadia Pharmaceuticals (ACAD)
| Year | EPS | Change |
|---|---|---|
| 2026 | $0.02 | -99.07% |
| 2025 | $2.30 | +69.01% |
| 2024 | $1.36 | +388.33% |
| 2023 | $0.28 | -208.06% |
| 2022 | -$0.26 | -3.81% |
| 2021 | -$0.27 | -84.83% |
| 2020 | -$1.76 | +16.42% |
| 2019 | -$1.52 | -11.11% |
| 2018 | -$1.70 | -26.73% |
| 2017 | -$2.33 | +4.03% |
| 2016 | -$2.24 | +38.62% |
| 2015 | -$1.61 | +74.53% |
| 2014 | -$0.92 | +121.88% |
| 2013 | -$0.42 | +46.51% |
| 2012 | -$0.28 | -33.92% |
| 2011 | -$0.43 | -211.83% |
| 2010 | $0.38 | -131.94% |
| 2009 | -$1.20 | N/A |